INDICES PROCEDURES DUE TO INTERMEDICA (GNDI3) INCORPORATION BY HAPVIDA (HAPV3)
February 11 2022 - 1:41PM
Bovespa News
INDICES PROCEDURES DUE TO INTERMEDICA (GNDI3) INCORPORATION BY
HAPVIDA (HAPV3)
In reference to the 016-2022-PRE Circular Letter, we hereby inform
you that, due to
INTERMEDICA (GNDI3) ordinary shares incorporation by HAPVIDA
(HAPV3), according to item 3.5
of the Concepts and Practices Manual for B3 Indices, B3 will adopt
the adjustment
procedures described below for February 14, 2022 opening.
GNDI3 - EXCLUSION
Index: IBOV, ICON, IBXL, IBXX, IGCT, IGNM, IBRA, MLCX, IVBX, ITAG,
IGCX, ICO2
HAPV3 - NEW QUANTITIES
Index: IBOV, ICON, IBXL, IBXX, IGCT, IGNM, IBRA, MLCX, IVBX,
ITAG
Theoretical Quantity: 4,411,767,198
Index: IGCX
Theoretical Quantity: 8,823,534,396
We reinforce that the indices' divisor for IBOV, ICON, IBXL, IBXX,
IGCT, IGNM, IBRA, MLCX,
IVBX, ITAG and IGCX will not change as a result of this event but
may be adjusted in the
case of corporate actions in other indices' constituents.
The values of the cash portion of R$ 5.16614751932 and
extraordinary dividends declared by GNDI3 of R$ 1.613026961 will be
reinvested on the portfolios.
The divisor for ICO2 index will be adjusted as usual.
HAPVIDA ON (BOV:HAPV3)
Historical Stock Chart
From Jun 2024 to Jul 2024
HAPVIDA ON (BOV:HAPV3)
Historical Stock Chart
From Jul 2023 to Jul 2024